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Abstract
Introduction: A study is made of the usefulness of cytokines (such as interleukin-6 (IL-6), interleukin-8 (IL-8), 
interleukin-10 (IL-10) and interleukin-12 (IL-12)) as markers of periimplant disease (mucositis and periimplanti-
tis). An increase in the levels of these cytokines in dental implant crevicular fluid may give rise to a lack of oste-
ointegration, �one loss or implant failure. 
O�jective: To review the literature relating IL-6, IL-8, IL-10 and IL-12 levels to dental implant surgery and peri-
implantitis.
Material and Method: A Pu�Med literature search was made of articles in English and Spanish, using the key 
words “cytokine and dental implants”, cytokine and periimplantitis”, “IL-6, IL-8, IL-10, IL-12 and dental im-
plants”, “IL-6, IL-8, IL-10, IL-12 and periimplantitis”. Fourteen articles were found and classified into two groups 
relating interleukin levels to: a) periimplant disease; and b) their influence upon dental implant osteointegration 
without periimplant disease.
Conclusions: An increase in interleukin levels is o�served in patients with periimplant disease, though there is 
controversy over the effect of interleukins in crevicular fluid and periimplantitis in relation to implant failure or 
the development of periimplant disease.
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Introduction
The usefulness of cytokines (such as interleukin-6 
(IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10) and 
interleukin-12 (IL-12)) as markers of periimplant dis-
ease (mucositis and periimplantitis) has �een investigat-
ed (1). The cytokines are multifunctional proteins and 
glycoproteins that act as intercellular regulatory factors 
at �oth local and systemic level. They are produced �y 
immunocompetent cells such as T lymphocytes and 
monocytes in local inflammatory tissue infiltrates. Peri-
odontal tissue components such as fibroblasts and epi-
thelial and endothelial cells also participate in cytokine 
formation during inflammatory responses (2).
Periodontal health depends on the local �alance among 
reactive and suppressor immune cells, their cytokines 
and mediators. Cytokines IL-6, IL-8 and IL-12 have 
proinflammatory functions, and induce bone reabsorp-
tion (1,3), while IL-10 exerts antiinflammatory effects 
(3). In the oral cavity it has �een seen that the plasma 
cytokine levels increase after surgery (2). In this con-
text, dental implant surgery releases a large amount of 
cytokines at local level as a �ody response to surgical 
aggression, and these levels gradually decrease over the 
su�sequent 8 months (3,4). Cytokine release after this 
period of time is regarded as an important factor in the 
development of periimplant disease.
The present study involves a literature review of the 
studies relating IL-6, IL-8, IL-10 and IL-12 levels to 
dental implant treatment, evaluating their implication 
in periimplant inflammation and their influence upon 
osteointegration, with a view to esta�lishing whether 
increased cytokine concentrations in the periimplant 
sulcus (crevicular fluid) are correlated to an early diag-
nosis of periimplant disease.
Material and Method
A Pu�Med literature search was made of articles in 
English and Spanish, using the key words “cytokine and 
dental implants”, cytokine and periimplantitis”, “IL-6, 
IL-8, IL-10, IL-12 and dental implants”, “IL-6, IL-8, IL-
10, IL-12 and periimplantitis”. Fourteen articles relat-
ing the levels of the a�ovementioned cytokines to dental 
implant treatment and periimplantitis were found (12 in 
vivo studies and two in vitro studies) – an evaluation �e-
ing made of interleukin influence upon periimplant dis-
ease and the osteointegration period of dental implants 
in the a�sence of periimplant disease.
Results and Discussion
Influence of interleukins 6, 8, 10 and 12 upon periim-
plant inflammation
The increase in cytokine concentration in the crevicu-
lar fluid of dental implants may lead to a lack of os-
teointegration, �one loss or implant failure (5-7). Bone 
is a dynamic tissue continuously su�ject to remodeling 
through rea�sorption and formation, these processes 
�eing controlled �y the local production of cytokines, 
among other factors (4).
Some of the studies in our review reported increased 
levels of IL-6, IL-8, IL-10 and IL-12 in periimplant 
disease, revealing their implication in the destruction 
of periimplant tissue and their usefulness as markers 
of periimplant disease (1,2,4, 7-9). In contrast, other 
authors o�served no relationship �etween IL-6 and IL-
10 levels and periimplant disease (2,7,8,10), discarding 
their implication in early dental implant loss (4).
Regarding IL-6, Liskmann et al. (1), on studying the 
levels of IL-6 in the crevicular fluid of the periimplant 
sulcus in 30 patients, recorded increased concentrations 
in patients with periimplant disease – a positive correla-
tion �eing o�served with the clinical parameters (�leed-
ing, pocket depth and gingival index). These authors 
examined the usefulness of cytokine concentration as 
a marker of periimplant disease, and in evaluating the 
capacity of the patient immune system to maintain an 
inflammatory balance. Konttinen et al. (9) recorded 
higher IL-6 levels in patients with periimplantitis than 
in healthy su�jects – the difference �eing statistically 
significant. These authors concluded that periimplant 
disease is amena�le to treatment with cytokine modula-
tors. In contrast, Mengel et al. (10), on comparing the 
IL-6 and IL-1β levels in 5 partially edentulous patients 
with severe periodontitis of the remaining teeth and su�-
jected to dental implant reha�ilitation versus patients 
without periodontal disease, reported higher levels in 
dental implant patients with periodontitis – the differ-
ence failing to reach statistical significance. Salcetti et 
al. (7) likewise recorded no differences in the levels of 
IL-6 on comparing patients with failed implants versus 
those with sta�le dental implants. Campos et al. (5), 
in 74 patients, analyzed the relationship �etween the 
polymorphic gene encoding for IL-6 and early dental 
implant loss. They concluded that such polymorphism 
does not constitute a genetic risk factor for early im-
plant loss. 
Nowzari et al. (6) in turn studied cytokine and �acterial 
levels �etween teeth and dental implants in healthy su�-
jects. An increased cytokine presence was noted in pa-
tients with dental implants (two-fold in the case of IL-8). 
This increase in cytokines was greater in the presence 
of a larger num�er of periodontal disease-inducing �ac-
teria. The authors concluded that although these were 
healthy individuals, there is an inevita�le and continu-
ous change in microorganisms and interleukins around 
teeth and implants.
As regards IL-10, Liskmann et al. (1) reported a higher 
concentration of IL-10 in patients with periimplantitis. 
In contrast, Duarte et al. (8) o�served no differences 
�etween healthy su�jects and patients with disease. In 
another study, Duarte et al. (11) evaluated the efficacy of 
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mechanical treatment for mucositis and periimplantitis. 
An improvement in the clinical parameters was noted, 
together with improvement in the levels of TNF-α and 
the OPG/RANKL ratio three months after such treat-
ment, without differences in the levels of IL -10 and IL-
12.
On correlating IL-12 concentrations in 48 patients to 
plaque accumulation, pocket depth, �leeding (spontane-
ous or in response to pro�ing) and suppuration, Duarte 
et al. (8) concluded that these concentrations are higher 
in advanced periimplantitis, with increased plaque ac-
cumulation, bleeding and pocket depth. They identified 
IL-12 as a critical factor in destruction of the periodon-
tium.
In an in vitro study, Bordin et al. (12) evaluated the fi-
�ro�lasts of patients with periimplantitis, patients with 
periodontitis, and healthy su�jects. They found that 
the fibroblasts of the patients with periimplantitis and 
periodontitis synthesized more IL-6 and IL-8, and thus 
presented a more accentuated proinflammatory profile 
(Ta�le 1).
On examining the composition of dental implants, Spy-
rou et al. (13) found that all titanium alloys of different 
compositions and roughness generated the same amount 
of interleukins.
Influence of interleukins upon the osteointegration pe-
riod of dental implants without periimplant disease
Variations are o�served in the levels of cytokines in cre-
vicular fluid from the time of dental implant surgery to 
one year after fitting of the prosthesis, without the obli-
gate presence of periimplant disease.
Twenty-four hours after placement of the dental im-
plants, Pietruski et al. (14) observed a significant in-
crease in IL-6 and IL-8 levels, thus reflecting the pres-
ence of local inflammation on the day after surgery, 
inherent to the surgical trauma, and forming part of the 
�ody regeneration and repair response. These levels in 
turn decreased four months after surgery. Khoury et al. 
(15), on exploring the influence of antibiotic prophy-
laxis prior to implant surgery, reported improvement in 
the clinical parameters one week after surgery, without 
modifications in cytokine levels (Table 2).
IL-6 IL- 8 IL- 10 IL -12 
Liskmann et al. 
2006 (1) 
Increase in periimplantitis 
(p<0.05) 
Increase in 
periimplantitis 
Konttinen et al. 
2006 (9) 
Increase in periimplantitis 
(p<0.05) 
   
Mengel et al. 
1996 (10) 
Increase in periimplantitis 
(p>0.05) 
   
Salcetti et al. 
1997 (7) 
Increase in healthy su�jects 
= periimplantitis 
   
Duarte et al. 
2009 (8) 
Healthy su�jects 
= periimplantitis 
Increase in 
periimplantitis 
Duarte et al. 
2009 (11) 
Same after 
treatment 
Same after 
treatment 
Bordin et al. 
2009 (12) 
Increase in periimplantitis 
(p<0.05) 
Increase in 
periimplantitis 
24 h postsurgery 4 months with prosthesis
8 months with 
prosthesis
Pietruski et al. 
2001 (14) Increase in IL-6, IL-8   
Schierano et al. 
2003 (3)  
- Increase in IL-10 
- IL-12 only in 
chronic inflammation 
Decrease in IL-6, 
IL-8, IL-10 
Schierano et al. 
2000 (4) 
Decrease in IL-6, 
IL-8, IL-10 
Table 1. Variations in the concentrations of different cytokines according to the literature.
Table 2. Variations in the concentrations of different cytokines according to time.
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Four months after prosthesis placement, Schierano et 
al. (3) recorded a considera�le increase in the levels 
of IL-10, reflecting the role of the latter in the regula-
tion of periimplant mucosal inflammation. The authors 
concluded that a short-term inflammatory response 
took place in the periodontium. Regarding IL-12, this 
cytokine was only detected after four months in one pa-
tient with chronic inflammation (Table 2).
Eight months after prosthesis placement, Schierano et 
al. (3,4) recorded a decrease in IL-6, IL-8 and IL-10, 
reflecting the influence of these cytokines in osteointe-
gration and in lessened �one rea�sorption secondary to 
dental loss (Ta�le 2).
Observations of the authors
Factors influencing cytokine levels:
Periimplant disease:
- An increase in IL-6, IL-10 and IL-12 in periimplant 
disease has �een demonstrated in three studies (1,9,11), 
while four articles (5,7,10,11) have reported no relation-
ship �etween periimplant disease and early implant loss 
and interleukin concentration.
Treatment:
- The interleukin levels in patients with periimplant dis-
ease do not improve after mechanical treatment (11).
Time:
- In patients without periimplant disease, the proin-
flammatory cytokines (7,8) decrease four months after 
surgery according to Pietruski et al. (14), and 8 months 
after prosthesis placement according to Schierano et al. 
(3,4). IL-12 does not appear under conditions of peri-
implant health, and disappears entirely 12 months after 
fitting the prosthesis. 
Surgery versus maintenance:
- It is important not to confuse the rise in cytokines o�-
served as a result of surgical trauma (secreted �y the 
�ody as part of the regeneration and repair response to 
injury) with the increase seen in inflammation caused 
by the bacterial biofilm in general, and by periodontal 
disease-inducing �acteria in the context of pre-esta�-
lished periimplantitis.
An increase in interleukins is o�served in patients with 
periimplant disease, though controversy exists over the 
effect of the interleukins in crevicular fluid and periim-
plantitis, regarding their correlation to implant failure 
or the development of periimplant disease.
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